carotenoids Not classified
No linked studies yet.
$27.24 $0.90 per serving
Product analysis
Ginkgold Eyes includes lutein that may help with selected aspects of contrast and glare. The preparation is not confirmed to match the one associated with those effects, making the expected benefit uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality38
The main eye-support ingredients have named forms, but their quality is not established. Naming a source does not by itself show how well the ingredients are absorbed.
Ingredient Transparency74
All listed amounts and most forms are disclosed, making the ingredients easier to compare. The proportions within the ginkgo preparation remain unclear.
Value For Money40
Value for the eye-support mixture cannot be established from the available price information. There is no reliable basis for calling its individual ingredients inexpensive or expensive.
Customer Satisfaction83
Customer ratings are favorable. Thousands of responses give a broad view of satisfaction, although no specific experiences are described.
Product Focus65
The formula focuses on eye support, but the expected benefits are limited and uncertain. Lutein and bilberry lack confirmed preparation matches, ginkgo findings are inconsistent, and the zeaxanthin serving falls below the relevant comparison amount.
- Format
Tablet - Container
- 60 Tablet(s)
- Per serving
- $0.90
- Customer rating
- 4.5 · 3,602 ratings
Goals
Impact
High effect
Lutein may support selected aspects of contrast and glare performance, but this marigold-derived declaration lacks a confirmed match to the reviewed active preparation. The bilberry extract also lacks a confirmed match to Omnica, whose limited findings concern focusing after display use. Ginkgo evidence is inconsistent and does not establish routine visual improvement. The 1 mg zeaxanthin serving falls below the saved amount threshold.
How this product is rated for Eye Health
Ingredient fit85
The formula centers on vision-related ingredients, although preparation uncertainty limits what their inclusion establishes. The counted amounts provide partial coverage of the saved comparison anchors; this does not measure expected visual improvement.
Goal fit
The formula centers on vision-related ingredients, although preparation uncertainty limits what their inclusion establishes.
Dose adequacy
The counted amounts provide partial coverage of the saved comparison anchors; this does not measure expected visual improvement.
Pathways40
Macular pigment and light filtering is the strongest tracked area, with smaller findings for focusing and circulation. Only macular pigment and light filtering reaches the comparison threshold; focusing and circulation remain below it.
Depth
Macular pigment and light filtering is the strongest tracked area, with smaller findings for focusing and circulation.
Breadth
Only macular pigment and light filtering reaches the comparison threshold; focusing and circulation remain below it.
Evidence48
Lutein leads the saved evidence finding, but its visual-performance findings remain limited and preparation matching is unresolved. The lutein and bilberry preparations lack confirmed matches to those reviewed; their source declarations do not establish clinical equivalence.
Evidence strength
Lutein leads the saved evidence finding, but its visual-performance findings remain limited and preparation matching is unresolved.
Studied preparation
The lutein and bilberry preparations lack confirmed matches to those reviewed; their source declarations do not establish clinical equivalence.
Formulation logic100
The counted ingredients have no missing required partners or identified configured conflicts. All counted ingredients meet the minimum amount comparison; this is not a guarantee of improved vision.
Partner coverage
No required partner is missing among counted ingredients; this does not establish the complete clinical AREDS combination.
Conflicts
No configured ingredient conflict was identified in the supplied calculation.
Effective doses
All counted ingredients meet the minimum amount comparison; this is not a guarantee of improved vision.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Total Carbohydrates | 1 Gram(s) | |
Bilberry (fruit) extract (Anthocyanins) | 120 mg | |
Ginkgold Ginkgo biloba extract (Ginkgo Flavone Glycosides, Terpene Lactones) | 60 mg | |
Lutein Carotenoid (Aztec Marigold extract) | 20 mg | |
Zeaxanthin Carotenoid (Aztec Marigold extract) | 1 mg |
Ginkgo (Ginkgo Flavone Glycosides, Terpene Lactones) · 60 mg OverallScore85
Each serving lists 60 mg of ginkgo leaf extract. The saved facts record 24% flavone and 6% terpene markers.
How this ingredient is rated
Composition and Label Disclosure70
The ginkgo leaf extract has recorded marker percentages.
Marker and Preparation Disclosure
The saved facts record 24% flavone and 6% terpene markers.
Declared Ginkgolic Acid Limit
The evaluation finds no qualifying ginkgolic acid limit in the saved facts; this does not establish a concentration.
Composition and Label Disclosure100
The ginkgo preparation and its individual serving amount are disclosed.
Individual Preparation Amount Disclosure
Each serving lists 60 mg of ginkgo leaf extract, with its amount and source disclosed.
Commercial Price and Usability
No price comparison was evaluated for ginkgo.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].